CC
Commodore Capital Portfolio holdings
AUM
$1.42B
1-Year Return
73.3%
This Quarter Return
+46.98%
1 Year Return
+73.3%
3 Year Return
+1,330.82%
5 Year Return
–
10 Year Return
–
AUM
$184M
AUM Growth
–
Cap. Flow
+$184M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
54.84%
Holding
28
New
28
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
C4 Therapeutics
CCCC
|
$15.9M |
| 2 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$12.5M |
| 3 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$12.2M |
| 4 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$9.05M |
| 5 |
KRON
Kronos Bio
KRON
|
$8.93M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 91.66% |
| 2 | Financials | 1.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cyclacel Pharmaceuticals
CYCC
$16.4M
| $2.07M | 1.12% |
+74
| New | +$2.07M |
|
27
Tempest Therapeutics
TPST
$44.9M
| $1.98M | 1.08% |
+4,744
| New | +$1.98M |
|
|
SNCE
28
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $1.07M | 0.58% |
+5,000
| New | +$1.07M |
|